Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS South Carolina Medical Policy Updates – February 2023
Click here to view the Blue Cross Blue Shield BCBS South Carolina Medical Policy Updates »
February 2023 BCBS South Carolina Medical Policy Updates:
- Ado-Trastuzumab Emtansine (Trastuzumab-DM1) for Treatment of HER-2 Positive Malignancies
- Allergen Testing
- Bariatric Surgery
- Belinostat (Beleodaq)
- Bevacizumab (Avastin) for Oncologic Use
- Blinatumomab (Blincyto)
- Brain Natriuretic Peptide (BNP)
- Brineura (cerliponase alfa)
- Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
- Clinical Trials
- Continuous Passive Motion (CPM) in the Home Setting
- Coronary Artery Calcium Scoring by: Electron-Beam Tomography (EBCT) OR Non-Contrast Coronary Computed Tomography (Non-contrast CCT)
- Cryoablation, Radiofrequency Ablation and Laser Ablation for Treatment of Chronic Rhinitis
- Cryosurgical Ablation of Primary or Metastatic Liver Tumors
- Dermatologic Applications of Photodynamic Therapy
- Diagnosis and Management of Idiopathic Environmental Intolerance (i.e., Clinical Ecology)
- Diagnostic Testing of Iron Homeostasis & Metabolism
- Donor Lymphocyte Infusion for Malignancies Treated With an Allogeneic Hematopoietic Cell Transplant
- efgartigimod alfa -Vyvgart™
- Endovascular Procedures for Intracranial Arterial Disease (Atherosclerosis and Aneurysms)
- Enhanced External Counterpulsation (EECP)
- Erythopoiesis Stimulating Agents and Darbepoetin Alfa (Aranesp)
- Extracranial Carotid Angioplasty/Stenting
- Gas Permeable Scleral Contact Lens
- Gender Affirmation Surgery and Hormone Therapy
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer
- General Genetic Testing, Germline Disorders
- Genetic Testing for CHARGE Syndrome
- Genetic Testing for Duchenne, Becker, Facioscapulohumeral, and Limb-Girdle Muscular Dystrophies
- Genetic Testing for Fanconi Anemia
- Genetic Testing for FMR1 Mutations (including Fragile X Syndrome)
- Genetic Testing for Germline Mutations of the RET Proto-Oncogene
- Genetic Testing for Hereditary Hemochromatosis
- Genetic Testing for Lipoprotein A Variant as a Decision Aid for Aspirin Treatment and/or CVD Risk Assessment
- Genetic Testing for Neurofibromatosis and Related Disorders
- Genetic Testing of CADASIL Syndrome
- Genetic Testing of Mitochondrial Disorders
- Golimumab (Simponi) for subcutaneous use
- Heart/Lung Transplant
- Hematopoietic Stem-Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
- Hemoglobin A1C
- Hereditary Angioedema Drug Therapy
- Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies
- Hypothermia to Prevent/Reduce Hair Loss During Chemotherapy
- Implantable Infusion Pump for Pain and Spasticity
- Implantation of Intrastromal Corneal Ring Segments
- Incapacitated Dependent Coverage
- Injectable Clostridial Collagenase for Fibroproliferative Disorders
- Interferential Current Stimulation
- Intra-Articular Hyaluronan Injections for Osteoarthritis
- Intraoperative Neurophysiologic Monitoring
- Intravitreal Angiogenesis Inhibitors for Choroidal Vascular Conditions
- Intravitreal Angiogenesis Inhibitors for Retinal Vascular Conditions
- Intravitreal Corticosteroid Implants
- Iontophoresis and Phonophoresis
- Keratoprosthesis
- Knee Braces, Orthopaedic Casts, Splints
- Laboratory Guideline Policy
- Laboratory/Pathology Services
- Laser-Assisted Tonsillectomy
- Magnetoencephalography/Magnetic Source Imaging
- Medical Policy Development and Review
- Microsatellite Instability and Tumor Mutational Burden Testing
- Neural Therapy
- Octreotide Acetate (Sandostatin)
- Outpatient Pulmonary Rehabilitation
- Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome
- Patient-Controlled Analgesia
- Percutaneous Electrical Nerve Field Stimulation for Functional Abdominal Pain Disorders
- Percutaneous Tibial Nerve Stimulation
- Pharmacogenetic Testing
- Positron Emission Mammography (PEM)
- Pre-implantation Genetic Testing
- Prenatal Testing for Fetal Aneuploidy
- Preventive Services for Non-Grandfathered (PPACA) Plans: USPSTF recommended services
- Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
- Quantose Impaired Glucose Tolerance (IGT) Test
- Radiation Oncology Services
- Ramucirumab (Cyramza®)
- Repository Corticotropin Injection
- Siltuximab (Sylvant)
- SPECT/CT Fusion Imaging
- Speech Therapy
- Spinal Cord and Dorsal Root Ganglion Stimulation
- Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction Due to Benign Prostatic Hyperplasia (BPH)
- Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
- Telemedicine
- Testing for Autism Spectrum Disorder and Developmental Delay
- Testing of Homocysteine Metabolism-Related Conditions
- Testosterone
- Thoracic-Lumbo-Sacral Orthosis With Pneumatics
- Thyroid Disease Testing
- Transanal Radiofrequency Treatment of Fecal Incontinence
- Transcatheter Pulmonary Valve Implantation
- Trastuzumab
- Treatment of Varicose Veins/Venous Insufficiency
- Ultrafiltration in Decompensated Heart Failure
- Vitamin D Testing
- Women’s Preventive Services
- Zika Virus Risk Assessment
Click here to view the Blue Cross Blue Shield BCBS South Carolina Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
